Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Headquarters & Offices:
Charlotte, NC
Chicago, IL
Seattle, WA
Kansas City, MO
St. Paul, MN
5 offices !! very good
RISK SHIELD $25 per month per user
https://www.encompinc.com/
Is this new? I had not seen it yet
Green. Strong close !
NEWS - Encompass Compliance Corporation (ENCC) Provides Services and Industry Knowledge to DATIA Members
CHARLOTTE, North Carolina, April 11, 2017 /PRNewswire/ --
Encompass Compliance Corp. (OTC PINK: ENCC), signed an agreement that allows them to provide compliance services to DATIA members. On 16th-18th May, DATIA has its annual conference and Encompass Compliance Corp. will be a featured speaker focusing on the challenges and nuances for drug testing rules in the workplace.
The Drug and Alcohol Testing Industry Association (DATIA) was founded in 1995 and has grown to represent over 1,500 member companies. DATIA now represents the entire spectrum of drug and alcohol service providers including collection sites, laboratories, consortiums/TPAs, MROs, and testing equipment manufacturers.
DATIA provides a critical function to its members in the following areas:
They serve as the coordinated voice for the industry on regulatory and legislative matters of drug and alcohol testing and collection issues, as well as drug-free workplace regulatory issues.
They inform members, of issues affecting their businesses through newsletters, legislative alerts and meetings.
They collect and disseminate information on drug and alcohol service and product providers through a national directory distributed to businesses and the general public.
DATIA's members provide drug testing products and services to over 1,000,000 (million) corporations throughout the U.S. These members provide products that test for: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine, barbiturates, ketamine, K2, tramadol, ETG. "Many of the major service and product suppliers to corporate America are members of DATIA. Therefore, we have a great audience to provide our Risk Shield Compliance services in support of our partner, DATIA," says Encompass CEO, Richard Sharp.
http://finance.yahoo.com/news/encompass-compliance-corporation-encc-provides-120000618.html
Encompass Compliance Corp. (OTC PINK: ENCC) has been selected by two of the three largest drug testing laboratories (Labs), to provide Risk Shield Services and real time industry updates to their respective customers. These agreements are pending legal approval.
The Labs have recognized the need to provide state specific compliance services to their employer customers. These two Labs service between 500,000 and 1,000,000 (million) employers in the U.S.
500,000 to 1,000,000 employers, means several million employees. This is resounding for this small business with only 3M of capitalization. It will be worth much more. 30 to 40 times more.
RE: ENCC Share Structure
RS
Richard Sharp <rsharp@encompinc.com>
Wednesday, April 5, 2017 10:35 AM
xxxxx,
All current details you have requested are on www.otcmarkets.com under our symbol ENCC.
Thanks,
Richard Sharp
CEO
Encompass Compliance, Corp.
rsharp@encompinc.com
866.328.7487
312.961.9118 Direct
Revenue up +360%
Revenue 2016 407,174.06
Revenue 2015 113,640.95
Published: mar 24, 2017 ; 2016 Annual Report
https://www.otcmarkets.com/financialReportViewer?symbol=ENCC&id=168168
With legalization in all these states (and Canada in 2018), the potential is very great.
Restricted shares
On August 29, 2014, 21,500,000 shares were issued to Richard Sharp, and another 21,500,000 shares were issued to William J. Judge.
William Judge and Richard Sharp will be receiving restricted shares of common stock in the amount of 15,000,000 for each (total of 30,000,000) in lieu of compensation for 2016. These will be issued in Q2 of 2017.
Richard Sharp 36,500,000 restricted shares
William Judge 36,500,000 restricted shares
73.000.000 restricted shares beneficial owners
more 10.659.846 restricted shares
Outstanding Shares 111,425,560 a/o Mar 01, 2017
Float 27,765,714 a/o Mar 01, 2017
Float 27,765,714 a/o Mar 01, 2017
https://www.otcmarkets.com/stock/ENCC/profile
Golden Cross
$ENCC
Correct. I agree with you.
Right, that's why up + 12% today ..
Very good article ..
Relax...
bid 1.5M 0.041
Revenue up +360%
Revenue 2016 407,174.06
Revenue 2015 113,640.95
Published: mar 24, 2017 ; 2016 Annual Report
https://www.otcmarkets.com/financialReportViewer?symbol=ENCC&id=168168
Restricted shares
On August 29, 2014, 21,500,000 shares were issued to Richard Sharp, and another 21,500,000 shares were issued to William J. Judge.
William Judge and Richard Sharp will be receiving restricted shares of common stock in the amount of 15,000,000 for each (total of 30,000,000) in lieu of compensation for 2016. These will be issued in Q2 of 2017.
Richard Sharp 36,500,000 restricted shares
William Judge 36,500,000 restricted shares
Float 27,765,714
The information for control persons is set forth for those deemed to be beneficial owners of more than 10% of any class of the Corporation’s equity securities.
C. Beneficial Shareholders.
Name Address No. of Shares Ownership %
Richard Sharp 21,500,000 34.73%
William J.Judge 21,500,000 34.73%
Notes Payable 0
Revenue up +260%
Revenue 2016 407,174.06
Revenue 2015 113,640.95
Published: mar 24, 2017 ; 2016 Annual Report
https://www.otcmarkets.com/financialReportViewer?symbol=ENCC&id=168168
I agree. I think exactly the same
$ENCC Drug Screening Industry to Grow on Heels of Rising THC, Opioid and Other Recreational Drug Use
April 4, 2017 News Tags: ENCC, ENCC News, Encompass Compliance Corp., Encompass Compliance Corp. News, GreenGro Technologies Inc., GreenGro Technologies Inc. News, GRNH, GRNH News, MYDX, MyDx Inc., MyDx Inc. News, MYDX News, Terra Tech Corp., Terra Tech Corp. News, TRTC, TRTC News
PALM BEACH, Florida, April 4, 2017 /PRNewswire/ --
MarketNewsUpdates.com News Commentary
In a recent article covering the Drug Screening Market, key factors responsible for the growth of the drug and alcohol testing industry are growing based on rising drug and alcohol abuse, along with increased funding by the U.S. Federal Governments for drug testing for THC, Opioids, alcohol and other recreational/addictive drug use. Furthermore, growing awareness on drug screening procedures across developing nations is a major factor boosting the market growth. Developments in the cannabis and drug screen industries alike for emerging companies include: Encompass Compliance Corp. (OTC: ENCC) and for some level cannabis operations companies: MyDx, Inc. (OTC: MYDX), 22nd Century Group, Inc. (NYSE: XXII), GreenGro Technologies, Inc. (OTC: GRNH), Terra Tech Corp. (OTC: TRTC).
Encompass Compliance Corp. (OTC: ENCC) Encompass Compliance Corp. has compiled critical data of the savings, by a fortune 500 Customer that has over 100,000 employees in the U.S. This respective company conducted a 6-state pilot implementing Encompass Compliance Corporation's Risk Shield services and "the results were amazing," the customer said. After just 6 months, the company's drug and alcohol claims were reduced by 20%, resulting in a $6.5 million savings on claim pay outs. The results were so impressive, they have decided to expand the program to more states. This was a post-accident only pilot testing for some key drugs such as: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine and ecstasy. "Compliance is key, but in addition to compliance you must aggressively pursue the benefits that exist for employers which can only be accomplished if state rules are followed. Helping our customers follow the rules is what we do," says Encompass Co-Founder and CRO, Bill Judge. Read this and more news for ENCC at: http://marketnewsupdates.com/news/encc.html
Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our Risk Shield solution provides organizations with up-to-date policies, a comprehensive resource center and real-time monitoring for drug and alcohol testing orders.
In other cannabis industry news or market performances of note:
MyDx, Inc. (OTCQB: MYDX) closed up over 12% on Monday trading over 71.5 Million shares by the market close. MyDx, Inc. is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust and Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user's hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest.
22nd Century Group, Inc. (NYSE: XXII) closed up over 4% on Monday at $1.23 trading over 1.2 Million shares by the market close. 22nd Century Group, Inc., a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced last week that leading scientists published more than 12 new studies involving 22nd Century's Very Low Nicotine (VLN) cigarettes at the 23rd Annual Meeting of the Society for Research on Nicotine & Tobacco (SRNT) held earlier this month in Florence, Italy. The event was attended by leading tobacco scientists and public health officials from around the world, including acclaimed university scientists, representatives from the FDA and other regulatory agencies, and tobacco industry executives.
GreenGro Technologies, Inc. (OTC: GRNH) closed up over 7% on Monday at $0.0665 trading over 5 Million shares by the market close. Greengro Technologies, Inc., a world-class provider of eco-friendly green technologies, late last week announced it has received a $600,000 down payment on a $7.4 million flagship three-acre turnkey off-grid PV-solar glass greenhouse from Fresh Local Produce of Ohio, an indoor hydroponic farming company based in Akron, Ohio. The companies expect to be breaking ground on the new facility in the third quarter of 2017.
Terra Tech Corp. (OTCQX: TRTC) close up over 5% on Monday at $0.291 trading over 9.5 Million shares by the market close. Terra Tech Corp., a vertically integrated cannabis-focused agriculture company, on this past Friday announced its financial results for the year ending December 31, 2016. See the full financial report at http://finance.yahoo.com/news/terra-tech-corp-reports-record-202500429.html
SOURCE MarketNewsUpdates.com
https://www.otcdynamics.com/encc-drug-screening-industry-to-grow-on-heels-of-rising-thc-opioid-and-other-recreational-drug-use/?utm_campaign=twitter&utm_medium=twitter&utm_source=twitter
$6.5 million savings
After just 6 months, the company's drug and alcohol claims were reduced 20%, resulting in a $6.5 million savings on claim pay outs.
The results were so impressive they have decided to expand the program to more states.
NEWS - Encompass Compliance Corporation (ENCC) Announces Financial Gains by a Key Customer
CHARLOTTE, North Carolina, April 4, 2017 /PRNewswire/ --
Encompass Compliance Corp. (OTC PINK: ENCC) has compiled critical data of the savings, by a fortune 500 Customer that has over 100,000 employees in the U.S.
This respective company conducted a 6-state pilot implementing Encompass Compliance Corporation's Risk Shield services and "the results were amazing," said the customer. After just 6 months, the company's drug and alcohol claims were reduced 20%, resulting in a $6.5 million savings on claim pay outs. The results were so impressive they have decided to expand the program to more states. This was a post-accident only pilot testing for some key drugs such as: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine and ecstasy. "Compliance is the key, but in addition to compliance you must aggressively pursue the benefits that exist for employers, which can only be accomplished if state rules are followed. Helping our customers follow the rules is what we do." says Encompass Co-Founder and CRO, Bill Judge.
http://finance.yahoo.com/news/encompass-compliance-corporation-encc-announces-120000682.html
$ENCC
Encompass Compliance Corp (OTCMKTS:ENCC) Rapidly Advancing Lab Testing Offerings
APRIL 3, 2017
http://mmjreporter.com/encompass-compliance-corp-otcmktsencc-rapidly-advancing-lab-testing-offerings-3064.html
NEWS - Encompass Compliance Corporation (ENCC) has Pending Deals With Two of Three Largest Drug Testing Laboratories
Encompass Compliance Corporation (ENCC) has Pending Deals With Two of Three Largest Drug Testing Laboratories
CHARLOTTE, North Carolina, March 30, 2017 /PRNewswire/ --
Encompass Compliance Corp. (OTC PINK: ENCC) has been selected by two of the three largest drug testing laboratories (Labs), to provide Risk Shield Services and real time industry updates to their respective customers. These agreements are pending legal approval.
The Labs have recognized the need to provide state specific compliance services to their employer customers. These two Labs service between 500,000 and 1,000,000 (million) employers in the U.S. "Millions of employers use lab based drug testing for THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine and barbiturates, to provide drug free workplaces. We will be providing the services that ensure employers are following the proper state laws when using these Lab services," says Encompass CEO Richard Sharp.
There will be joint marketing activities such as webinars, industry seminars and real time alerts, providing compliance services to these employers. More details of the execution of these relationships will follow.
About Encompass Compliance Corp.
Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our solutions provide organizations with up to date policies, a comprehensive resource center and real-time monitoring for drug & alcohol testing orders.
https://www.otcmarkets.com/stock/ENCC/news/Encompass-Compliance-Corporation--ENCC--has-Pending-Deals-With-Two-of-Three-Largest-Drug-Testing-Laboratories?id=154676&b=y
bid 1M
$ENCC MJ stock ; the next $NDEV ; up +42% ; NEWS
Float only 27M
NEWS
Encompass Compliance Corporation (ENCC) has Pending Deals With Two of Three Largest Drug Testing Laboratories
March 30, 2017
https://www.otcmarkets.com/stock/ENCC/news/Encompass-Compliance-Corporation--ENCC--has-Pending-Deals-With-Two-of-Three-Largest-Drug-Testing-Laboratories?id=154676&b=y
$ENCC MJ stock ; NEWS ; the next $NDEV ; up +42%
Float only 27M
NEWS
Encompass Compliance Corporation (ENCC) has Pending Deals With Two of Three Largest Drug Testing Laboratories
March 30, 2017
Encompass Compliance Corp. (OTC PINK: ENCC) has been selected by two of the three largest drug testing laboratories (Labs), to provide Risk Shield Services and real time industry updates to their respective customers. These agreements are pending legal approval.
https://www.otcmarkets.com/stock/ENCC/news/Encompass-Compliance-Corporation--ENCC--has-Pending-Deals-With-Two-of-Three-Largest-Drug-Testing-Laboratories?id=154676&b=y
$ENCC MJ stock ; the next $NDEV ; up +42%
Float only 27M
NEWS
Encompass Compliance Corporation (ENCC) has Pending Deals With Two of Three Largest Drug Testing Laboratories
March 30, 2017
Encompass Compliance Corp. (OTC PINK: ENCC) has been selected by two of the three largest drug testing laboratories (Labs), to provide Risk Shield Services and real time industry updates to their respective customers. These agreements are pending legal approval.
https://www.otcmarkets.com/stock/ENCC/news/Encompass-Compliance-Corporation--ENCC--has-Pending-Deals-With-Two-of-Three-Largest-Drug-Testing-Laboratories?id=154676&b=y
the next $NDEV
$ENCC
shares outstanding are really around 5 million shares
David T. Veal, Morgan Stanley, Research Division - Research Analyst [21]
--------------------------------------------------------------------------------
My question is, what is the public float on the shares? And what kind of a -- the volume has been tremendous all year long, and what is your best guess on where the buying and selling is coming from?
--------------------------------------------------------------------------------
Jack E. Stover, Interpace Diagnostics Group, Inc. - CEO, President and Director [22]
--------------------------------------------------------------------------------
Yes, David. Thanks for joining us. Yes, as we take a look at the float, I'll give you a sense of where is -- or where it was on a presplit basis. Before our financings and the restructuring, we had a roughly 18 million shares outstanding. And our float at that time was basically about 11 million shares. Add to that some of the financings that have taken place and changes, et cetera, but the reverse stock split was effectively a 1-for-10 reverse stock split. So we're probably somewhere in that range. But in total, our shares outstanding are really around 5 million shares. And today, I believe we traded around 2 million shares. So there's a lot of interest in the stock. Quite frankly, while I'm very interested in it, and I spend a lot of time talking to prospective investors, we don't have a lot of time to really track down the investment process as to who's in and who's out and how that activity happens. But we're certainly thrilled to see the kind of volume we have and the kind of support we have in the marketplace.
http://finance.yahoo.com/news/edited-transcript-idxg-earnings-conference-030721618.html
$IDXG